Furthermore, the incidence of mutations in BRCA1/2 of ovarian cancer patients with high-grade serous carcinoma was significantly higher than other histological types statistically (P = 0.005) (Table 2). This evidence concerns the gene BRCA1 and ovarian carcinoma.